Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

University of Toronto

$37,000.00

Deciphering the determinants of biomaterial uptake by liver immune cells

EF 2018-19

Résumé
A major challenge in biomaterial delivery is that virtually all formulations of biomaterials tested to date have a marked predisposition to sequester non-specifically in the liver. The overarching theme of my research program is to identify determinants of biomaterial uptake in the liver in order to modulate off-target accumulation and improve specific delivery. An important question that must be answered in order to modulate NP uptake in the liver is the question of which immune cells are found in the liver. *The main hypothesis of this research is that hepatic biomaterial uptake will be related to the phenotype of the intrahepatic cells and to the inflammatory state of the liver. To test this hypothesis, we will fully characterize intrahepatic cells in the mouse and human liver, we will test NP uptake in these identified populations, and will examine how manipulation of these cells via inflammatory stimuli might impact NP uptake. The following specific aims will be examined in these studies:*Aim 1. Identify and characterize the liver cellular environment. We will employ an immunological and genomics based approach to describe the liver cellular landscape.*Aim 2. We will examine nanoparticle uptake in hepatic cell populations. We will leverage previous knowledge of cell populations in the liver and novel populations identified using immunologic and gene expression-based approaches to sort populations and test NP uptake in vitro (human cells) as well as tracking NP uptake in real-time in vivo (mice).*Aim 3. We will examine whether NP uptake is modifiable. For example, we will examine whether transient induction of inflammation of the liver may have an impact on accumulation of NP in the liver. In this aim, we will use flow cytometry and intravital imaging of mice to examine the degree of NP uptake and the kinetics of NP uptake under various inflammatory conditions.*The proposed research is significant, as gaining insight into NP uptake in liver immune cells will help in the development of strategies to limit off-target accumulation of NPs in the liver, leading to a higher efficiency of specific delivery of NPs to targeted sites. Also, a clear understanding of the distribution of NPs in liver immune cells will lay the groundwork to develop biotechnologies to reprogram the immune response in the liver, which will be of benefit in situations in which inappropriate immune signaling promotes fibrosis/cirrhosis and or tumor development. Thus, this research will provide a platform for reprogramming other organs such as the gut, in which inappropriate inflammatory activation remains a significant hurdle to overcome. Therefore, this research program will provide valuable new insights for field of nanoimmunology, which will be of benefit to both our academic and industry partners and will have important intellectual and economic impact for Canada.*
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
RGPIN-2018-05958
Name nom
MacParland, Sonya
Department département
Laboratory Medicine and Pathobiology
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2018
Competition year année de concours
2018
Award amount
37000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
5109
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Intra-cellular targeting
Research subject fr
Cibles intra-cellulaires
Partie
1
Nb partie
5
Application title
Deciphering the determinants of biomaterial uptake by liver immune cells
Keyword
NSERC
Application summary
A major challenge in biomaterial delivery is that virtually all formulations of biomaterials tested to date have a marked predisposition to sequester non-specifically in the liver. The overarching theme of my research program is to identify determinants of biomaterial uptake in the liver in order to modulate off-target accumulation and improve specific delivery. An important question that must be answered in order to modulate NP uptake in the liver is the question of which immune cells are found in the liver. *The main hypothesis of this research is that hepatic biomaterial uptake will be related to the phenotype of the intrahepatic cells and to the inflammatory state of the liver. To test this hypothesis, we will fully characterize intrahepatic cells in the mouse and human liver, we will test NP uptake in these identified populations, and will examine how manipulation of these cells via inflammatory stimuli might impact NP uptake. The following specific aims will be examined in these studies:*Aim 1. Identify and characterize the liver cellular environment. We will employ an immunological and genomics based approach to describe the liver cellular landscape.*Aim 2. We will examine nanoparticle uptake in hepatic cell populations. We will leverage previous knowledge of cell populations in the liver and novel populations identified using immunologic and gene expression-based approaches to sort populations and test NP uptake in vitro (human cells) as well as tracking NP uptake in real-time in vivo (mice).*Aim 3. We will examine whether NP uptake is modifiable. For example, we will examine whether transient induction of inflammation of the liver may have an impact on accumulation of NP in the liver. In this aim, we will use flow cytometry and intravital imaging of mice to examine the degree of NP uptake and the kinetics of NP uptake under various inflammatory conditions.*The proposed research is significant, as gaining insight into NP uptake in liver immune cells will help in the development of strategies to limit off-target accumulation of NPs in the liver, leading to a higher efficiency of specific delivery of NPs to targeted sites. Also, a clear understanding of the distribution of NPs in liver immune cells will lay the groundwork to develop biotechnologies to reprogram the immune response in the liver, which will be of benefit in situations in which inappropriate immune signaling promotes fibrosis/cirrhosis and or tumor development. Thus, this research will provide a platform for reprogramming other organs such as the gut, in which inappropriate inflammatory activation remains a significant hurdle to overcome. Therefore, this research program will provide valuable new insights for field of nanoimmunology, which will be of benefit to both our academic and industry partners and will have important intellectual and economic impact for Canada.*